HEDIS Archives

The Authors’ Own Words: Predictors of HEDIS Treatment Initiation and Engagement among Patients with Opioid Use Disorder across Seven Health Systems

Nov 29, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Predictors of HEDIS Treatment Initiation and Engagement among Patients with Opioid Use Disorder across Seven Health Systems

Cynthia I. Campbell, PhD, MPH; Constance Weisner, DrPH, MSW; Ingrid A. Binswanger, MD, MPH, MS; Gwen T. Lapham, PhD, MPH, MSW; Brian K. Ahmedani, PhD, LMSW; Bobbi Jo H. Yarborough, PsyD; Irina V. Haller, PhD, MS; Andrea Altschuler, PhD; Rulin C. Hechter, MD, PhD; Amy M. Loree, PhD; & Andrea H. Kline-Simon, MS

Substance Abuse Vol. 40, Iss. 3, 2019

“The rates of AOD initiation and engagement for OUD patients vary widely and leave considerable room for improvement. Health systems appear to have more success at engaging younger patients in treatment, which may have positive implications for these patients long-term if they can stay engaged. The primary care and inpatient settings can present important opportunities for health systems to initiate and engage patients in treatment.”

The Authors’ Own Words: Factors Associated with Healthcare Effectiveness Data and Information Set (HEDIS) Alcohol and Other Drug (AOD) Measure Performance in 2014-2015

Nov 27, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Factors Associated with Healthcare Effectiveness Data and Information Set (HEDIS) Alcohol and Other Drug (AOD) Measure Performance in 2014-2015

Constance Weisner, DrPH, MSW; Cynthia I. Campbell, PhD, MPH; Andrea Altschuler, PhD; Bobbi Jo H. Yarborough, PsyD; Gwen T. Lapham, PhD, MPH, MSW; Ingrid A. Binswanger, MD, MPH, MS; Rulin C. Hechter, MD, PhD; Brian K. Ahmedani, PhD, LMSW; Irina V. Haller, PhD, MS; Stacy A. Sterling, DrPH, MSW; Dennis McCarty, PhD; Derek D. Satre, PhD; & Andrea H. Kline-Simon, MS

Substance Abuse Vol. 40, Iss. 3, 2019

“Our goal was to identify opportunities to develop patient- and system-level interventions to facilitate initiation and engagement in AOD services, particularly among those who may be less likely to receive care. Initiation and engagement rates varied greatly, but they were low. Findings identified those over age 65, women, Hispanics, Black/African American and Asians (versus white) as less likely to initiate and those aged 30-49 and/or co-occurring conditions were more likely to engage. Primary care was the department with highest initiation rates, but those patients were less likely to engage in treatment. Focusing on these could help health systems develop interventions that facilitate AOD-IET.”

The Authors’ Own Words: Psychiatric comorbidity and HEDIS measures of alcohol and other drug treatment initiation and engagement across seven health systems

Nov 27, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Psychiatric comorbidity and HEDIS measures of alcohol and other drug treatment initiation and engagement across seven health systems

Amy M. Loree, PhD; Hsueh-Han Yeh, PhD; Derek D. Satre, PhD; Andrea H. Kline-Simon, MS; Bobbi Jo H. Yarborough, PsyD; Irina V. Haller, PhD, MS; Cynthia I. Campbell, PhD, MPH; Gwen T. Lapham, PhD, MPH, MSW; Rulin C. Hechter, MD, PhD; Ingrid A. Binswanger, MD, MPH, MS; Constance Weisner, DrPH, MSW; & Brian K. Ahmedani, PhD, LMSW

Substance Abuse Vol. 40, Iss. 3, 2019

“This paper examines the influence of psychiatric comorbidity on alcohol and other drug (AOD) treatment initiation and engagement among a large, diverse sample of health system patients with newly diagnosed AOD use disorders. Nearly two-thirds of patients with newly identified AOD use disorders also had a comorbid psychiatric disorder. Our findings indicated that identification of comorbid psychiatric disorders may increase initiation of AOD treatment but not engagement. We also found that the setting in which AOD use disorders are first identified among patients with comorbid psychiatric disorders may play a role in treatment initiation and engagement. Overall, these findings suggest that health care systems may need to consider adopting alternative approaches to improve identification and support of patients in need of treatment for both psychiatric and AOD use disorders.”

The Authors’ Own Words: Healthcare Effectiveness Data and Information Set (HEDIS) Measures of Alcohol and Drug Treatment Initiation and Engagement among People living with HIV and HIV-uninfected Patient

Nov 26, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Healthcare Effectiveness Data and Information Set (HEDIS) Measures of Alcohol and Drug Treatment Initiation and Engagement among People living with HIV and HIV-uninfected Patient

Rulin C. Hechter, MD, PhD; Michael A. Horberg, MD, MAS; Constance Weisner, DrPH, MSW; Cynthia I. Campbell, PhD, MPH; Richard Contreras, MS; Lie-Hong Chen, DrPH; Bobbi Jo H. Yarborough, PsyD; Gwen T. Lapham, PhD, MPH, MSW; Irina V. Haller, PhD, MS; Brian K. Ahmedani, PhD, LMSW; Ingrid A. Binswanger, MD, MPH, MS; Andrea H. Kline-Simon, MS; & Derek D. Satre, PhD

Substance Abuse Vol. 40, Iss. 3, 2019

“The findings of this study suggest people living with HIV and substance use disorders generally have greater number of comorbidities, including hepatitis C. Yet utilization of behavioral health services is low in this population. This is a clinically concerning pattern and requires more intensive support from the health systems and HIV specialists.“

The Authors’ Own Words: The Prevalence of HEDIS Initiation and Engagement in Treatment among Patients with Cannabis Use Disorders in Seven U.S. Health Systems

Nov 25, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

The Prevalence of HEDIS Initiation and Engagement in Treatment among Patients with Cannabis Use Disorders in Seven U.S. Health Systems

Substance Abuse Vol. 40, Iss. 3, 2019

“This observational cohort study of 15,202 patients with a cannabis use disorder (CUD) from seven U.S. healthcare systems is the first known study to describe rates of HEDIS-defined alcohol and other drug use disorder (AOD) measures for initiation and engagement in treatment among patients with a newly diagnosed CUD. For these patients, rates of initiation and engagement were low, with considerable variation across index diagnosis setting, AOD comorbidity at index diagnosis, and patient characteristics. Greater adherence to these system-level treatment measures will likely require strong leader and provider partnerships to improve recognition of and linkage to evidence-based treatment for CUD, particularly for those patients with less AOD severity who could still benefit from treatment.“